DR. GUALBERTO RUAO is a Founder of Genaissance Pharmaceuticals, Inc. He
has extensive biotechnology management experience and is a pioneer in
several haplotyping technologies for profiling genome diversity stemming
from population and evolutionary genetics. He is the inventor of CAS
System (U.S. patent 5,427,911) for the rapid determination of sequence
variation, which is now used for HIV diagnosis and AIDS clinical
management. He has consulted with the Connecticut Laboratory of Forensic
Science to establish the State Police’s DNA analysis unit and with
Connecticut Innovations, Inc. to evaluate technologies of portfolio
companies. He is considered one of the industry’s leaders in the impact
of gene variation on clinical medicine and drug development. Dr. Ruao
serves as a member of the Governor’s Council on Economic Competitiveness
and Technology. He also serves as a board member of the Connecticut
Technology Council, and is on the board of the Biotechnology Industry
Organization’s Emerging Companies Section. Dr. Ruao received his MD and
PhD in Human Genetics from Yale University School of Medicine, where he
was a Fellow of the Medical Scientist training Program and received a
Ford Foundation Fellowship. He received his BA from Johns Hopkins
University (Phi Beta Kappa).
